BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33009518)

  • 21. Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.
    Liu Y; Wang JX; Nie ZY; Wen Y; Jia XJ; Zhang LN; Duan HJ; Shi YH
    J Exp Clin Cancer Res; 2019 Oct; 38(1):439. PubMed ID: 31747963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
    Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S
    Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
    Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
    Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
    Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
    Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
    [No Abstract]   [Full Text] [Related]  

  • 27. Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.
    Cowman SJ; Fuja DG; Liu XD; Tidwell RSS; Kandula N; Sirohi D; Agarwal AM; Emerson LL; Tripp SR; Mohlman JS; Stonhill M; Garcia G; Conley CJ; Olalde AA; Sargis T; Ramirez-Torres A; Karam JA; Wood CG; Sircar K; Tamboli P; Boucher K; Maughan B; Spike BT; Ho TH; Agarwal N; Jonasch E; Koh MY
    Clin Cancer Res; 2020 Sep; 26(18):4970-4982. PubMed ID: 32586940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway.
    Yin L; Li W; Xu A; Shi H; Wang K; Yang H; Wang R; Peng B
    EBioMedicine; 2020 Jan; 51():102596. PubMed ID: 31911271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNF43 is a Novel Tumor Suppressor and Prognostic Indicator in Clear Cell Renal Cell Carcinoma.
    Zhu D; Zhang L; Shi X; Gao S; Yue C; Zhang L; Bai Y; Wang Q; Okada A; Yasui T; Wang C; Cui X; Zuo L
    Oncol Res; 2021 Jul; ():. PubMed ID: 34215350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA PCAT1 drives clear cell renal cell carcinoma by upregulating YAP via sponging miR-656 and miR-539.
    Wang R; Zheng B; Liu H; Wan X
    Cell Cycle; 2020 May; 19(10):1122-1131. PubMed ID: 32286142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma.
    He C; Chen ZY; Li Y; Yang ZQ; Zeng F; Cui Y; He Y; Chen JB; Chen HQ
    BMC Nephrol; 2019 Apr; 20(1):127. PubMed ID: 30975094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
    Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3.
    Shen T; Miao S; Zhou Y; Yi X; Xue S; Du B; Tang C; Qu L; Fu D; Jia R; He H
    Cell Commun Signal; 2022 Sep; 20(1):152. PubMed ID: 36153596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma.
    Xu Y; Li L; Yang W; Zhang K; Zhang Z; Yu C; Qiu J; Cai L; Gong Y; Zhang Z; Zhou J; Gong K
    J Exp Clin Cancer Res; 2023 Jul; 42(1):159. PubMed ID: 37415241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
    Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
    Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
    Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.